| Financial Year |
March 31 2023 |
| Monetary Funds |
373,617,457.87 |
| Held-for-trading Financial Assets |
952,977,113.51 |
| Notes Receivable |
-- |
| Accounts Receivable |
440,431,600.31 |
| Advances to Suppliers |
65,576,507.01 |
| Other Receivables |
12,309,589.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
214,479,624.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,291,763.23 |
| Total Current Assets |
2,114,109,026.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
191,535,822.05 |
| Investment Properties |
10,321,712.31 |
| Fixed Assetes |
690,031,186.92 |
| Under-construction Projects |
474,797,309.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
271,021,294.68 |
| R&D expenses |
414,617,747.74 |
| Goodwill |
57,602,564.92 |
| Long-Term Deferred and Prepaid Expenses |
8,496,050.66 |
| Deferred Income Tax Assets |
45,159,242.90 |
| Other Non-Current Assets |
23,791,218.97 |
| Sub-Total of Non-Current Assets |
2,366,219,981.96 |
| Total Assets |
4,480,329,008.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
153,672,055.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
135,513,048.27 |
| Taxes Payable |
82,027,406.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
290,207,138.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,732,918.37 |
| Other Current Liabilities |
1,548,371.80 |
| Sub-Total of Current Liabilities |
684,423,592.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,175,937.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
173,647,090.22 |
| Total Liabilities |
858,070,682.60 |
| Paid-In Capital(Or Share Stock) |
1,673,257,958.00 |
| Capital Surplus |
431,054,574.71 |
| Surplus Reserve |
292,832,788.22 |
| LESS:Treasury Stock |
207,407,604.61 |
| Undistributed Profits |
1,229,827,584.05 |
| Minority Stockholder's Interest |
202,693,025.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,419,565,300.37 |
| Owner's Equity（Stockholder's Equity） |
3,622,258,325.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,480,329,008.05 |
